Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93103

32 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
September 21, 2023
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Central Admixture Pharmacy Services Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

32 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 32

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7

D-0001-2024
Recall number
D-0001-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,762 Syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275858, Exp. 10/11/2023; 17-275967, 17-275981, Exp. 10/15/2023

Distribution pattern

Nationwide in the USA

drug · product 2 of 32

ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1

D-0002-2024
Recall number
D-0002-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
4,775 5 mL Syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275224, 17-275225, 17-275233, 17-275235, 17-275253, 17-275259, 17-275263, 17-275267 Exp. 10/2/2023; 17-275340, Exp. 10/3/2023; 17-275512, Exp. 10/5/2023; 17-275633, 17-275657, Exp. 10/8/2023.

Distribution pattern

Nationwide in the USA

drug · product 3 of 32

ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6004-1

D-0003-2024
Recall number
D-0003-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,590 5 mL Syringes.

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275252, 17-275276, Exp. 10/2/2023; 17-275525, Exp. 10/5/2023

Distribution pattern

Nationwide in the USA

drug · product 4 of 32

lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1

D-0004-2024
Recall number
D-0004-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,992 5 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275788, Exp. 10/10/2023; 17-275872, Exp. 10/11/2023; 17-275922, Exp. 10/12/2023; 17-275972, 17-275973, Exp. 10/15/2023.

Distribution pattern

Nationwide in the USA

drug · product 5 of 32

PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1

D-0005-2024
Recall number
D-0005-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
3,384 10 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275231, 17-275232, Exp. 10/2/2023; 17-275563, 17-275567, 17-275573, 17-275580, Exp. 10/8/2023; 17-275767, 17-275784, Exp. 10/10/2023;

Distribution pattern

Nationwide in the USA

drug · product 6 of 32

PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6008-1

D-0006-2024
Recall number
D-0006-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
3,081 syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275323, 17-275345, Exp. 10/3/2023; 17-275642, 17-275643, 17-275671, Exp. 10/8/2023; 17-275675, 17-275677, Exp. 10/9/2023; 17-276188, Exp. 10/18/2023

Distribution pattern

Nationwide in the USA

drug · product 7 of 32

PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1

D-0007-2024
Recall number
D-0007-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
19,510 10 mL syringes.

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275152, 17-275154, 17-275155, 17-275156, 17-275163, Exp. 10/1/2023; 17-275234, 17-275236, 17-275251, 17-275268, 17-275270, 17-275277, Exp. 10/2/2023; 17-275283, 17-275294, 17-275313, Exp. 10/3/2023; 17-275469, 17-275471, 17-275473, 17-275480, 17-275481, 17-275482, 17-275483, 17-275484, 17-275485, 17-2754990, 17-2754991, 17-2754993, Exp. 10/4/2023; 17-275558, 17-275654, 17-275667, Exp. 10/8/2023; 17-275722, 17-275737, Exp. 10/9/2023; 17-275768, 17-275804, 17-275805, Exp. 10/10/2023; 17-275847, 17-275849, 17-275857, 17-275882, Exp. 10/11/2023; 17-275923, Exp. 10/12/2023; 17-275983, 17-275984, Exp. 10/15/2023; 17-276123, Exp. 10/17/2023; 17-276125, 17-276126, Exp. 10/18/2023

Distribution pattern

Nationwide in the USA

drug · product 8 of 32

rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6010-1

D-0008-2024
Recall number
D-0008-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,389 5 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275634, Exp. 10/8/2023; 17-275860, Exp. 10/11/2023; 17-276174, Exp. 10/18/2023

Distribution pattern

Nationwide in the USA

drug · product 9 of 32

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1

D-0009-2024
Recall number
D-0009-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,767 3 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275621, Exp. 10/8/2023; 17-275693, 17-275725, Exp. 10/9/2023

Distribution pattern

Nationwide in the USA

drug · product 10 of 32

fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2071-2

D-0010-2024
Recall number
D-0010-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
598 10 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275476, Exp. 10/4/2023;17-275875, Exp. 10/11/2023

Distribution pattern

Nationwide in the USA

drug · product 11 of 32

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

D-0011-2024
Recall number
D-0011-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
688 50 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275341, Exp. 10/3/2023; 17-275853, Exp. 10/11/2023

Distribution pattern

Nationwide in the USA

drug · product 12 of 32

fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4

D-0012-2024
Recall number
D-0012-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
5,378 100 mL bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275314, 17-275319, 17-275320, 17-275324, 17-275327, 17-275328, 17-275349, Exp. 10/3/2023; 17-275510, 17-275531, 17-275536, 17-275541, 17-275548, Exp. 10/5/2023; 17-275656, Exp. 10/8/2023; 17-275714, Exp. 10/9/2023; 17-275766, 17-275786, 17-275787, 17-275802, Exp. 10/10/2023; 17-275918, 17-275926, Exp. 10/12/2023; 17-275951, Exp. 10/13/2023; 17-275966, 17-275975, 17-275977, Exp. 10/15/2023; 17-276103, Exp 10/17/2023.

Distribution pattern

Nationwide in the USA

drug · product 13 of 32

fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5

D-0013-2024
Recall number
D-0013-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,792 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275164, exp. 10/1/2023; 17-275623, 17-275631, 17-275640, 17-275649,17-275650, 17-275655, 17-275660, Exp. 10/8/2023; 17-275712, 17-275713, 17-275721, 17-275723, 17-275727, Exp. 10/9/2023; 17-276232, Exp. 10/19/2023.

Distribution pattern

Nationwide in the USA

drug · product 14 of 32

fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2074-1

D-0014-2024
Recall number
D-0014-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
403 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275517, Exp. 10/5/2023; 17-275862, Exp. 10/11/2023; 17-275980, Exp. 10/15/2023; 17-276036, Exp. 10/16/2023.

Distribution pattern

Nationwide in the USA

drug · product 15 of 32

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

D-0015-2024
Recall number
D-0015-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
895 50 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275165, 17-275166, Exp. 10/1/2023; 17-275217, Exp. 10/2/2023; 17-275715, Exp. 10/9/2023; 17-276035, Exp. 10/16/2023; 17-276112, Exp. 10/17/2023

Distribution pattern

Nationwide in the USA

drug · product 16 of 32

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

D-0016-2024
Recall number
D-0016-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
60 250 mL bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275929, Exp. 10/12/2023,

Distribution pattern

Nationwide in the USA

drug · product 17 of 32

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2

D-0017-2024
Recall number
D-0017-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
190 250 mL bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275974, 17-275979, Exp. 10/15/2023; 17-276110, Exp. 10/17/2023; 17-276234, Exp. 10/19/2023.

Distribution pattern

Nationwide in the USA

drug · product 18 of 32

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

D-0018-2024
Recall number
D-0018-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
419 50 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275475, Exp. 10/4/2023; 17-276117, Exp. 10/17/2023

Distribution pattern

Nationwide in the USA

drug · product 19 of 32

fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-1

D-0019-2024
Recall number
D-0019-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
50, 3 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275284, Exp. 10/3/2023.

Distribution pattern

Nationwide in the USA

drug · product 20 of 32

fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2

D-0020-2024
Recall number
D-0020-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
174, 5 mL syringes.

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275479, Exp. 10/4/2023; 17-275852, Exp. 10/11/2023

Distribution pattern

Nationwide in the USA

drug · product 21 of 32

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3

D-0021-2024
Recall number
D-0021-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
476, 50 mL Syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275464, Exp. 10/4/2023; 17-275850, Exp. 10/11/2023.

Distribution pattern

Nationwide in the USA

drug · product 22 of 32

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-4

D-0022-2024
Recall number
D-0022-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
240 100 mL bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275704, Exp. 10/9/2023.

Distribution pattern

Nationwide in the USA

drug · product 23 of 32

fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-5

D-0023-2024
Recall number
D-0023-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
71 100 mL bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275322, Exp. 10/3/2023.

Distribution pattern

Nationwide in the USA

drug · product 24 of 32

fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2001-2

D-0024-2024
Recall number
D-0024-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
962 30 mL syringes.

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275321, Exp. 10/3/2023; 17-275779, 17-275790, Exp. 10/10/2023.

Distribution pattern

Nationwide in the USA

drug · product 25 of 32

fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7

D-0025-2024
Recall number
D-0025-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,459 30 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275223, 17-275275, Exp. 10/2/2023; 17-275928, Exp. 10/12/2023; 17-276088, 17-276118, Exp. 10/17/2023.

Distribution pattern

Nationwide in the USA

drug · product 26 of 32

succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6011-2

D-0026-2024
Recall number
D-0026-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
3,590 10 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275343, Exp. 10/3/2023; 17-275472, 17-275489, Exp.10/4/2023; 17-275876, Exp. 10/11/2023; 17-275976, 17-275985, Exp. 10/15/2023; 17-276204, Exp. 10/18/2023.

Distribution pattern

Nationwide in the USA

drug · product 27 of 32

HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-1

D-0027-2024
Recall number
D-0027-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,190 30 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275680, Exp. 10/8/2023; 17-275945, Exp. 10/13/2023; 17-276094, Exp. 10/17/2023

Distribution pattern

Nationwide in the USA

drug · product 28 of 32

HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2

D-0028-2024
Recall number
D-0028-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
1,190 50 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275728, Exp. 10/9/2023; 17-275791, 17-275803, Exp. 10/10/2023; 17-276244, Exp. 10/20/2023.

Distribution pattern

Nationwide in the USA

drug · product 29 of 32

HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1

D-0029-2024
Recall number
D-0029-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
4,550 30 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275315, Exp.10/3/2023; 17-275466, 17-275477, Exp.10/4/2023; 17-276102, Exp. 10/17/2023; 17-276221, Exp. 10/19/2023

Distribution pattern

Nationwide in the USA

drug · product 30 of 32

HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2

D-0030-2024
Recall number
D-0030-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
274 30 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot:17-275266, Exp. 10/2/2023; 17-275666, Exp. 10/8/2023.

Distribution pattern

Nationwide in the USA

drug · product 31 of 32

HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2012-1

D-0031-2024
Recall number
D-0031-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
2,664 30 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275339, Exp. 10/3/2023; 17-275478, 17-275488, Exp. 10/4/2023; 17-275620, Exp. 10/8/2023; 17-275777, 17-275793, Exp. 10/10/2023; 17-275863, 17-275958, Exp. 10/11/2023; 17-276027, Exp. 10/16/2023; 17-275730, Exp. 10/9/2023.

Distribution pattern

Nationwide in the USA

drug · product 32 of 32

HYDROmorphone in dextrose 5%, 0.5 mg/5 mL, (0.1 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2012-1

D-0032-2024
Recall number
D-0032-2024
Initiated
September 21, 2023
Classification
Class II
Status
Terminated
Quantity
398 5 mL syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility:

Code information

Lot: 17-275730, Exp 10/09/2023

Distribution pattern

Nationwide in the USA